68
Participants
Start Date
January 31, 2016
Primary Completion Date
September 19, 2018
Study Completion Date
February 21, 2019
PRIMVAC
3 different dosages of VAR2CSA protein (20µg - 50µg and 100µg)
GLA-SE
2.56 µg of GLA content
Alhydrogel
0.85 mg og Aluminium content
Placebo
0.9% Na cl
CIC 1417, Paris
CNRFP, Ouagadougou
Collaborators (1)
European Vaccine Initiative
OTHER
Recherche Clinique Paris Descartes Necker Cochin Sainte Anne
OTHER
Centre national de recherche et de formation sur le paludisme
OTHER_GOV
EUCLID Clinical Trial Platform
OTHER
Institut National de la Santé Et de la Recherche Médicale, France
OTHER_GOV